Androgenetic alopecia as an early marker of benign prostatic hyperplasia

Journal of the American Academy of Dermatology

Volumn 66, Issue 3, 2012, Pages 401-408

  Arias Santiago, Salvador ^a,b,c   Arrabal Polo, Miguel Angel ^a,b,c   Buendía Eisman, Agustín ^a,b,c   Arrabal Martín, Miguel ^a,b,c   Gutiérrez Salmerón, María Teresa ^a,b,c   Girón Prieto, María Sierra ^a,b,c   Jimenez Pacheco, Antonio ^a,b,c   Calonje, Jaime Eduardo ^a,b,c   Naranjo Sintes, Ramón ^a,b,c   Zuluaga Gomez, Armando ^a,b,c   Serrano Ortega, Salvio ^a,b,c  

^a HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^b Urology Unit   (Spain)

^c ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

androgenetic alopecia; androgens; benign prostatic hyperplasia; maximum urinary flow; prostate volume

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN; GLUCOSE; INSULIN; PROSTATE SPECIFIC ANTIGEN;

ABDOMINAL OBESITY; ADULT; AGED; ARTICLE; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MALE TYPE ALOPECIA; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; SCORING SYSTEM; SYSTOLIC BLOOD PRESSURE; TRANSRECTAL ULTRASONOGRAPHY; URINALYSIS; URINE FLOW RATE; URINE FLOWMETER;

ADULT; AGE OF ONSET; AGED; ALOPECIA; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSTATE; PROSTATIC HYPERPLASIA; URINATION;

EID: 84857447750     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2010.12.023     Document Type: Article

References (49)

1. S. Arias-Santiago, M.T. Gutiérrez-Salmerón, A. Buendía-Eisman, M.S. Girón-Prieto, and R. Naranjo-Sintes Hypertension and aldosterone levels in women with early-onset androgenetic alopecia Br J Dermatol 162 2010 786 789
2. S. Arias-Santiago, M.T. Gutiérrez-Salmerón, L. Castellote-Caballero, and R. Naranjo-Sintes Elevated aldosterone levels in patients with androgenetic alopecia Br J Dermatol 161 2009 1196 1198
3. S. Arias-Santiago, M.T. Gutiérrez-Salmerón, L. Castellote-Caballero, A. Buendía-Eisman, and R. Naranjo-Sintes Male androgenetic alopecia and cardiovascular risk factors: a case-control study Actas Dermosifiliogr 101 2010 248 256
4. P.K. Siiteri, and J.D. Wilson Dihydrotestosterone metabolism in prostate hypertrophy: the formation of content of dihydrotestosterone in the hypertrophic prostate of man J Clin Invest 49 1970 1735 1745
5. P.C. Walsh, G.M. Hutchins, and L.L. Ewing Tissue content of dihydrotestosterone in human prostatic hyperplasia is not supranormal J Clin Invest 72 1983 1772 1777 (Pubitemid 14229057)
6. A.L. Dallob, N.S. Sadick, W. Unger, S. Lipert, L.A. Geissler, and S.L. Gregoire The effect of finasteride, a 5 alpha-reductase inhibitor, on scalp skin testosterone and dihydrotestosterone concentrations in patients with male pattern baldness J Clin Endocrinol Metab 79 1994 703 706 (Pubitemid 24286388)
7. K.D. Bingham, and D.A. Shaw The metabolism of testosterone by human scalp skin J Endocrinol 87 1973 111 121
8. A. Vermeulen, L. Verdonck, and J.M. Kaufman A critical evaluation of simple methods for the estimation of free testosterone in serum J Clin Endocrinol Metab 84 1999 3666 3672 (Pubitemid 30645223)
9. W. Chen, C.C. Yang, G.Y. Chen, M.C. Wu, H.M. Sheu, and T.S. Tzai Patients with a large prostate show a higher prevalence of androgenetic alopecia Arch Dermatol Res 296 2004 245 249 (Pubitemid 40064191)
10. B.R. Oh, S.J. Kim, J.D. Moon, H.N. Kim, D.D. Kwon, and Y.H. Won Association of benign prostatic hyperplasia with male pattern baldness Urology 51 1998 744 748 (Pubitemid 28261925)
11. C.S. Agrawal, P.R. Chalise, and B.B. Bhandari Correlation of prostate volume with international prostate symptom score and quality of life in men with benign prostatic hyperplasia Nepal Med Coll J 10 2008 104 107
12. G. Faydaci, E. Bilal, P. Necmettin, T. Fatih, O. Asuman, and K. Uur Baldness, benign prostate hyperplasia, prostate cancer and androgen levels Aging Male 11 2008 189 192
13. G. Severi, R. Sinclair, J.L. Hopper, D.R. English, M.R. McCredie, and P. Boyle Androgenetic alopecia in men aged 40-69 years: prevalence and risk factors Br J Dermatol 149 2003 1207 1213 (Pubitemid 38058097)
14. P. Greenwald, A. Damon, V. Kirmss, and A.K. Polan Physical and demographic features of men before developing cancer of the prostate J Natl Cancer Inst 53 1974 341 346
15. W. Demark-Wahnefried, J.M. Schildkraut, D. Thompson, S.M. Lesko, L. McIntyre, and P. Schwingl Early onset baldness and prostate cancer risk Cancer Epidemiol Biomarkers Prev 9 2000 325 328 (Pubitemid 30165446)
16. E. Hawk, R.A. Breslow, and B.I. Graubard Male pattern baldness and clinical prostate cancer in the epidemiologic follow-up of the first National Health and Nutrition Examination Survey Cancer Epidemiol Biomarkers Prev 9 2000 523 527 (Pubitemid 30313897)
17. C.C. Hsieh, A. Thanos, D. Mitropoulos, C. Deliveliotis, C.S. Mantzoros, and D. Trichopoulos Risk factors for prostate cancer: a case-control study in Greece Int J Cancer 80 1999 699 703 (Pubitemid 29066281)
18. G.G. Giles, G. Severi, R. Sinclair, D.R. English, M.R. McCredie, and W. Johnson Androgenetic alopecia and prostate cancer: findings from an Australian case-control study Cancer Epidemiol Biomarkers Prev 11 2002 549 553 (Pubitemid 34615162)
19. R. Bermudo, D. Abia, D. Benitez, A. Carrió, R. Vilella, and A.R. Ortiz Discovery of genomic alterations through coregulation analysis of closely linked genes: a frequent gain in 17q25.3 in prostate cancer Ann N Y Acad Sci 1210 2010 17 24
20. W.R. Anderson, N.M. Harris, and S.A. Holmes Hormonal treatment for male-pattern hair loss: implications for cancer of the prostate? BJU Int 90 2002 682 685 (Pubitemid 35356633)
21. G.L. Andriole, D.G. Bostwick, O.W. Brawley, L.G. Gomella, M. Marberger, F. Montorsi REDUCE Study Group Effect of dutasteride on the risk of prostate cancer N Engl J Med 362 2010 1192 1202
22. G.J. Gormeley, E. Stoner, R.C. Bruskewitz, J. Imperato-McGinley, P.C. Walsh, and J.D. McConnel The effect of finasteride in me with prostatic benign prostatic hyperplasia N Engl J Med 327 1992 1185 1191
23. O. Yoshida, K. Oishi, Y. Okada, Y. Mizutani, Y. Itokawa, and T. Tomoyoshi Effect of long-term administration of finasteride (MK-906), an inhibitor of 5 alpha-reductase, in patients with benign prostatic hyperplasia Hinyokika Kiyo 42 1996 323 331 (Pubitemid 26182843)
24. E.A. Olsen, M. Hordinsky, D. Whiting, D. Stough, S. Hobbs, M.L. Ellis Dutasteride Alopecia Research Team The importance of dual 5alpha-reductase inhibition in the treatment of male pattern hair loss: results of a randomized placebo-controlled study of dutasteride versus finasteride J Am Acad Dermatol 55 2006 1014 1023 (Pubitemid 44716474)
25. S. Arias-Santiago, M.T. Gutiérrez-Salmerón, A. Buendía-Eisman, M.S. Girón-Prieto, and R. Naranjo-Sintes Sex hormone-binding globulin and risk of hyperglycemia in patients with androgenetic alopecia J Am Acad Dermatol 65 2011 48 53
26. J.B. Hamilton Male hormone stimulation is a prerequisite and an incitant common baldness Am J Anat 71 1942 451 480
27. S. Anderson, D.M. Berman, E.P. Jenkins, and D.W. Ruxxel Deletion of steroid 5 alpha-reductase 2 gene in male pseudohermaphroditism Nature 354 1991 159 161 (Pubitemid 21896802)
28. P.C. Walsh, J.D. Madden, M.J. Harrod, J.L. Godstein, P.C. MacDonald, and J.D. Wilson Familial incomplete male pseudohermaphroditism type II: decreased dihydrotestosterone formation in pseudo-vaginal perineoscrotal hypospadias N Engl J Med 291 1974 944 949
29. J. Galić, and D. Simunović Prostate disease prevalence with epidemiological and hormonal analysis in randomly selected male population in Croatia Coll Antropol 32 2008 1195 1202
30. L. Adorini, G. Penna, B. Fibbi, and M. Maggi Vitamin D receptor agonists target static, dynamic, and inflammatory components of benign prostatic hyperplasia Ann N Y Acad Sci 1193 2010 146 152
31. K.E. Andersson, and A. Arner Urinary bladder contraction and relaxation: physiology and pathophysiology Physiol Rev 84 2004 935 986 (Pubitemid 38823771)
32. J.C. Nickel Inflammation and benign prostatic hyperplasia Urol Clin North Am 35 2008 109 115 (Pubitemid 350166524)
33. K.L. Lee, and D.M. Peehl Molecular and cellular pathogenesis of benign prostatic hyperplasia J Urol 172 2004 1784 1791 (Pubitemid 39363056)
34. R. Bergman, R. Schein-Goldshmid, Z. Hochberg, O. Ben-Izhak, and E. Sprecher The alopecias associated with vitamin D-dependent rickets type IIA and with hairless gene mutations: a comparative clinical, histologic, and immunohistochemical study Arch Dermatol 141 2005 343 351 (Pubitemid 40365450)
35. B. Baltalarli, F. Bir, N. Demirkan, and G. Abban The preventive effect of vitamin D3 on radiation-induced hair toxicity in a rat model Life Sci 78 2006 1646 1651 (Pubitemid 43262956)
36. J. Wang, Z. Lu, and J.L. Au Protection against chemotherapy-induced alopecia Pharm Res 23 2006 2505 2514
37. M.J. Bolland, R.W. Ames, A.B. Grey, A.M. Horne, B.H. Mason, and G.D. Gamble Does degree of baldness influence vitamin D status? Med J Aust 189 2008 674 675
38. K.T. Amor, R.M. Rashid, and P. Mirmirani Does D matter? The role of vitamin D in hair disorders and hair follicle cycling Dermatol Online J 16 2010 3
39. S. Arias-Santiago, M.T. Gutiérrez-Salmerón, L. Castellote-Caballero, A. Buendía-Eisman, and R. Naranjo-Sintes Androgenetic alopecia and cardiovascular risk factors in men and women: a comparative study J Am Acad Dermatol 63 2010 420 429
40. S. Arias-Santiago, M.T. Gutiérrez-Salmerón, A. Buendía-Eisman, M.S. Girón-Prieto, and R. Naranjo-Sintes A comparative study of dyslipidemia in men and woman with androgenic alopecia Acta Derm Venereol 90 2010 485 487
41. S. Arias-Santiago, M.T. Gutiérrez-Salmerón, A. Buendía-Eisman, M.S. Girón-Prieto, and R. Naranjo-Sintes Lipid levels in women with androgenetic alopecia Int J Dermatol 49 2010 1340 1342
42. S. Arias-Santiago, M.T. Gutiérrez-Salmerón, L. Castellote-Caballero, and R. Naranjo-Sintes Factores de riesgo cardiovascular en pacientes con alopecia androgenética: síndrome metabólico y ateromatosis carotidea Actual Med 94 2009 14 23
43. S.H. Lee, J.C. Kim, J.Y. Lee, J.H. Kim, C.Y. Oh, and S.W. Lee Effects of obesity on lower urinary tract symptoms in Korean BPH patients Asian J Androl 11 2009 663 668
44. J.K. Parsons, H.B. Carter, A.W. Partin, B.G. Windham, E.J. Metter, and L. Ferrucci Metabolic factors associated with benign prostatic hyperplasia J Clin Endocrinol Metab 91 2006 2562
45. F. Di Silverio, V. Gentile, A. De Matteis, G. Mariotti, V. Guiseppe, and P.A. Luigi Distribution of inflammation, pre-malignant lesions, incidental carcinoma in histologically confirmed benign prostatic hyperplasia: a retrospective analysis Eur Urol 43 2003 164 175 (Pubitemid 36221971)
46. S. Furukawa, T. Fujita, M. Shimabukuro, M. Iwaki, Y. Yamada, and Y. Nakijima Increased oxidative stress in obesity and its impact on metabolic syndrome J Clin Invest 114 2004 1752 1761 (Pubitemid 40385531)
47. S. Rohrmann, A.M. De Marzo, E. Smit, E. Giovannucci, and E.A. Platz Serum C-reactive protein concentration and lower urinary tract symptoms in older men in the Third National Health and Nutrition Examination Survey (NHANES III) Prostate 62 2005 27 33 (Pubitemid 39614290)
48. A.V. Sarma, C.A. Jaffe, D. Schottenfeld, R. Dunn, J.E. Montie, and K.A. Cooney Insulin-like growth factor-1, insulin-like growth factor binding protein-3, and body mass index: clinical correlates of prostate volume among black men Urology 59 2002 362 367 (Pubitemid 34189735)
49. S.A. Kaplan Patients with a large prostate show a higher prevalence of androgenetic alopecia J Urol 174 2005 1905